# China NMPA Drug Inspection - Sinopharm Group Feng Lexing (Foshan) Pharmaceutical Co., Ltd. - Angong Niuhuang Wan

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-feng-lexing-foshan-pharmaceutical-co-ltd/0ffd1759-33a7-4437-8855-cf2085bb3344/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Feng Lexing (Foshan) Pharmaceutical Co., Ltd. published July 28, 2022. Drug: Angong Niuhuang Wan. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Sinopharm Group Feng Lexing (Foshan) Pharmaceutical Co., Ltd.
- Publication Date: 2022-07-28
- Drug Name: Angong Niuhuang Wan
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-feng-lexing-foshan-pharmaceutical-co-ltd/376b6530-82b0-4f7c-a8dd-c3283e918c96/
